A prospective study of appropriate follow-up interval for high-risk group of branch duct type intraductal papillary mucinous neoplasms of the pancreas
Not Applicable
Completed
- Conditions
- Branch duct type intraductal papillary mucious neoplasms of the pancreas
- Registration Number
- JPRN-UMIN000016989
- Lead Sponsor
- Sendai City Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 155
Inclusion Criteria
Not provided
Exclusion Criteria
1) A concurrence of pancreatic malignancies at the time of diagnosis of IPMN. 2) The contraindication or rejection for the imaging examinations by EUS or MRCP. 3) The patients from whom the informed consent cannot be obtained. 4) The patients who are judged inappropriate for the participation for this study by the attending doctor.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method